# Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

> **NCT01136395** · PHASE2 · COMPLETED · sponsor: **University of Giessen** · enrollment: 85 (actual)

## Conditions studied

- Kidney Transplantation
- Rituximab (RTx)
- Living Donors
- Immunology
- Virus

## Interventions

- **DRUG:** Rituximab
- **PROCEDURE:** living donor transplantation
- **PROCEDURE:** deceased donor transplantation

## Key facts

- **NCT ID:** NCT01136395
- **Lead sponsor:** University of Giessen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2019-06-18
- **Final completion:** 2019-06-18
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2019-10-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01136395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01136395, "Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01136395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*